Dosulepin EP Impurity C | CAS 1531-85-7 - Request Quote
Dosulepin EP Impurity C
| SZ CAT No: | SZ-D059004 |
| CAS No | 1531-85-7 |
| Mol.F. | C19H23NOS |
| Mol.Wt. | 313.46 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dosulepin EP Impurity C is chemically (11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]thiepin-11-ol (as per EP). Dosulepin EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Dosulepin EP Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dosulepin .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1531-85-7
Purchase 1531-85-7
Order 1531-85-7
Enquire 1531-85-7
price of 1531-85-7
1531-85-7 Supplier
1531-85-7 Manufacturer
1531-85-7 Exporter
buy high quality Dosulepin EP Impurity C
Purchase Dosulepin EP Impurity C
Dosulepin EP Impurity C suppliers
Dosulepin EP Impurity C manufacturers
Dosulepin EP Impurity C price
Order Dosulepin EP Impurity C
Enquire Dosulepin EP Impurity C
Dosulepin EP Impurity C cost
Dosulepin EP Impurity C Supplier
Dosulepin EP Impurity C Distributor
Dosulepin EP Impurity C for Method Validation
Dosulepin Reference Standard
Dosulepin EP Impurity C for ANDA Filing
Dosulepin EP Impurity C for Forced Degradation Studies
Dosulepin EP Impurity C Identification Standards
Dosulepin EP Impurity C for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.